The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,280.00
Bid: 6,300.00
Ask: 6,320.00
Change: -40.00 (-0.63%)
Spread: 20.00 (0.317%)
Open: 6,320.00
High: 6,430.00
Low: 6,280.00
Prev. Close: 6,320.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Current Trading

16 Jun 2020 07:00

RNS Number : 0272Q
4imprint Group PLC
16 June 2020
 

16 June 2020

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a further update on the effect of the COVID-19 pandemic on the Group's trading and operations.

 

In our last COVID-19 update issued on 7 April 2020, we noted that the spread of the pandemic and associated 'Safer at Home' or similar directives had resulted in order counts reducing to about 20% of prior year level. As the partial or full lifting of these restrictions began in many US states in May and early June, weekly order counts have steadily increased and are now approaching 50% of the 2019 comparative. Importantly, we continue to acquire new customers and the new-to-existing customer ratio has remained broadly stable over this period.

 

Since the beginning of the pandemic, we have continued to provide excellent service to our customers through an expanded 'work from home' capability. Our two US locations in Oshkosh, Wisconsin and our office in Manchester, UK have now reopened. Where practical, however, team members continue to work from home, allowing us to implement robust social distancing protocols in our facilities. In line with our culture, the health, safety and wellbeing of our people remains our top priority, and we have continued to prioritise the retention of our team members throughout this difficult period. Our team is ready and very motivated to service the recovering demand that we are seeing.

 

Cash conservation was a clear focus for the Group early in the COVID-19 crisis. Action has been taken to control discretionary and capital spend. We executed a thoughtful and effective recalibration of the marketing strategy to significantly decrease marketing investment throughout the period yet stay connected with our existing customers and maintain our brand awareness. This strategy has also given us the flexibility to ramp up the marketing as justified by market conditions.

 

The Group's balance sheet and liquidity position remain strong. At the end of May 2020, the Group had cash balances of $28.1m, and no debt. This is after the payment in May of the $9.4m planned lump sum contribution to the Group's defined benefit pension plan. We also have a working capital facility of $20m.

 

The Group intends to announce its half year results for the 26 weeks ended 27 June 2020 on Thursday 13 August 2020. In the meantime, the Board remains confident in 4imprint's strategy, business model and market position, culminating in the delivery of longer-term value for all stakeholders.

 

 

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFWIESSEFM
Date   Source Headline
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn
19th Jul 20227:00 amRNSTrading Statement
7th Jul 20222:26 pmRNSHolding(s) in Company
24th Jun 20229:37 amRNSEBT Purchase
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company
17th May 20227:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.